版本:
中国

BRIEF-Spark Therapeutics completes rolling biologics license application submission to FDA

May 18 Spark Therapeutics Inc

* Spark Therapeutics completes rolling biologics license application submission to FDA for investigational gene therapy voretigene neparvovec Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐